This compound is primarily used in cancer research, specifically targeting the K-Ras G12C mutation, which is commonly found in various cancers such as lung, colorectal, and pancreatic cancers. It functions as a selective inhibitor, binding to the mutated K-Ras protein and preventing its activation, thereby blocking downstream signaling pathways that promote tumor growth and survival. Researchers utilize this compound to study the mechanisms of K-Ras-driven cancers and to develop potential therapeutic strategies. It is also employed in preclinical studies to evaluate the efficacy and safety of targeting the K-Ras G12C mutation in cancer treatment.